Ohio to share in $465M settlement with EpiPen maker Mylan

The bulk of the money will go to Medicaid programs in all 50 states. Mylan, meanwhile, does not admit wrongdoing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.